Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians

Rationale & Objective: Research in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) has focused on reducing treatment toxicities, notably through reduction of exposure to glucocorticoids. Glucocorticoid-sparing therapies such as avacopan are not widely available in many countries...

Descripció completa

Dades bibliogràfiques

Autors principals:	David Massicotte-Azarniouch, Mark Canney, Priscilla Karnabi, Peter A. Merkel, Rachel B. Jones, Ruth J. Pepper, Alan D. Salama, Vimal K. Derebail, Nataliya Milman, Mats Junek, Christian Pagnoux, David R.W. Jayne, Michael Walsh
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-08-01
Col·lecció:	Kidney Medicine
Matèries:	Anti-neutrophil cytoplasmic antibody-associated vasculitis cyclophosphamide glucocorticoid rituximab survey
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2590059524000694
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!